The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a new study.
..
.
HIV drug shows efficacy in treating mouse models of HER2+ breast cancer, study suggests
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a new study.
There are currently 1 users browsing this thread. (0 members and 1 guests)
Posting Permissions
Quote